Index C
- Caffeine
- in hypotension 848, 849
- sleep disorders with 451t
- CAGE questionnaire 336-337
- Calcaneus
- bursitis in 547t
- Calcidiol
- in hypocalcemia 575
- Calcification
- of anterolateral spinal ligaments 488-489
- aortic 940
- in aortic regurgitation 870
- in aortic valve stenosis 866
- on chest x-ray 829
- in mitral regurgitation 876
- pancreatic 1103
- Calcipotriene 1255
- Calcitonin
- in hypercalcemia 579
- in multiple myeloma--related hypercalcemia 736-737
- in osteoporosis 480
- Calcitriol
- in hypocalcemia 575
- in osteomalacia 485
- Calcium
- age-related malabsorption of 1002
- in arrhythmogenesis 886
- blood 572, 1384t
- in chronic renal failure 964
- decrease in (hypocalcemia) 573-576, 574t
- increase in (hypercalcemia) 576-580, 577t
- drug interactions with 589t
- in hyperphosphatemia 582
- metabolism of 572-580, 574t, 577t
- in myocardial contractility 818-819, 821
- in osteomalacia 486
- in osteoporosis 478
- in Paget's disease of bone 483
- Calcium alginate dressings 1274t
- Calcium carbonate 575
- Calcium channel, antibodies to 522, 523
- Calcium channel blockers 888t (see also specific drugs)
- in achalasia 1036
- in angina 856-857
- dosage of 887
- in heart failure 908
- in hypertension 842t
- after myocardial infarction 862t
- urinary incontinence with 967t
- Calcium chloride 571
- Calcium gluconate
- in hypermagnesemia 584
- in muscle cramps 534
- in tetany 575-576
- Calcium pyrophosphate dihydrate crystal deposition disease 496-497
- Calcium test, in Zollinger-Ellison syndrome 1049
- Calculus(i)
- bile duct 1012, 1127
- gallbladder 1005-1006, 1116, 1125-1126
- estrogen replacement therapy and 1215
- intestinal migration of 1127-1128
- pancreatitis with 1127
- Caloric testing 189
- Cancer 714-724 (see also specific sites and types)
- anemia with 679
- anorectal 1144-1145
- bile duct 1151-1152
- bladder 991-994, 991t
- breast 1217-1228, 1217t, 1219t, 1221t, 1223t-1224t, 1226t-1227t
- estrogen replacement therapy and 1215, 1218
- cells in 5
- cervical 1205-1206
- colonic 1141-1144
- depression and 311t
- dermatomyositis and 525, 526
- ear 1342-1343
- endometrial 1203-1204, 1203t
- estrogen replacement therapy and 1214
- esophageal 1134-1136
- gallbladder 1151
- gastric 1137-1139
- gastrointestinal 1134-1153, 1146t
- hepatic 1149-1150
- hypercalcemia in 576, 577, 578, 579-580
- hyperphosphatemia in 582
- immune senescence and 1358
- incidence of 714-715, 715f, 715t
- of kidneys 987-991, 989t
- lung 800-806, 801t, 802t
- mesenteric 1152-1153
- mortality rates for 13, 13t
- oral 1021-1023
- ovarian 1204, 1205t
- estrogen replacement therapy and 1214
- pain management in 722
- palliative care in 115-123
- pancreatic 1145-1148, 1146t
- penile 1190-1191
- peritoneal 1152-1153
- prevention of 51t, 716
- prostate 1183-1186, 1185t
- rectal 1141-1145
- of renal pelvis 994-995
- resources on 1411-1412
- salivary gland 1030
- screening for 48t, 716-717, 718t
- selenium and 594
- skin 1278-1284, 1283t
- small-intestine 1139-1140
- terminal 723-724 (see also Dying patient)
- testicular 1191
- thyroid 653-654
- treatment of 717-722
- of ureter 994-995
- of urethra 995-996
- vaginal 1207-1208
- venous thromboembolism and 691-692
- vulvar 1206-1207
- Candesartan
- in hypertension 842t
- Candidiasis
- drugs for 1376t
- genital 1201, 1210
- oral 1018-1019, 1376t
- Canes 211
- Capacity 128-130
- decisional 128
- loss of 130
- surrogate decision making and 135-138
- Capecitabine 720t, 1226t
- Capsaicin 394t, 396
- in osteoarthritis 493
- Capsulitis 221
- Captopril
- in heart failure 907
- in hypertension 842t
- Carbachol 1300t
- Carbamazepine
- drug interactions with 68t, 1375t
- in pain management 394t
- in trigeminal neuralgia 1350
- Carbapenems 1370t
- Carbenicillin 1368t
- Carbidopa-levodopa
- in parkinsonism 439-440, 449t
- sleep disorders with 451t
- Carbohydrate metabolism, disorders of 624-642, 1097 (see also Diabetes mellitus)
- Carbon dioxide, in respiratory failure 787
- Carbonic anhydrase inhibitors
- in glaucoma 1297, 1300t
- in metabolic alkalosis 587
- renal tubular acidosis with 586
- Carbon monoxide
- parkinsonism with 444t
- Carcinoembryonic antigen (CEA) 1142
- Carcinoid tumor
- colorectal 1141-1144
- small-intestine 1139-1140
- Carcinoma (see Cancer)
- Carcinosarcoma, pancreatic 1145
- Cardiac (see Heart)
- Cardiac catheterization
- in angina 857
- in cardiovascular disorders 825t, 832
- Cardiac index, age-related changes in 816t
- Cardiac output
- age-related changes in 819-820
- reduction in, in syncope 174
- Cardiomyopathy 911-914
- diabetic 626
- dilated 911-912
- hypertrophic 912-914
- restrictive 914
- Cardiopulmonary resuscitation
- do-not-resuscitate orders and 138-139
- Cardiovascular disorders 833-950
- diagnostic evaluation of 822-832, 825t, 827t, 832t
- drugs for
- adverse effects of 63t-65t
- aging effects on 60t
- patient history in 822-823
- physical examination in 823-824
- prevention of 48t, 49t
- resources on 1412
- surgical risk and 244, 247t
- tertiary prevention in 51
- Cardiovascular system
- age-related changes in 813-822, 814t-815t, 902
- in hypertension 821-822
- during exercise 816t, 820-821
- function of, age-related changes in 814t-815t, 815-822, 816t, 817f, 818f
- lifestyle effects on 822
- surgery on 942-950, 945t
- Cardioversion, in atrial fibrillation 891, 892
- Cardioverter-defibrillator, implantable
- in heart failure 910
- after myocardial infarction 863t
- in ventricular tachycardia 894
- Caregiver 142-143
- in alcoholism management 340
- in COPD 787
- in dementia 365, 376t, 377
- in diabetes mellitus 636
- in elder abuse 155
- as geriatric interdisciplinary team member 77
- patient sexuality and 1158
- pressure sores and 1275-1276
- prevention efforts of 49
- in rehabilitation 267
- resources for 1412
- respite care for 92-93
- speech disorders and 426t
- Carhart notch 1339
- Caries 1013-1015
- Carisoprodol, adverse effects of 64t
- Carmustine, sexual function and 1164t
- Carotene 589
- in malabsorption 1101
- Carotid arteries 404f-405f
- aneurysm of 938
- atherosclerosis of 403-404, 406-407, 406t
- disease of
- surgery and 246-247
- examination of 33-34
- kinking of 938
- obstruction of
- transient blindness with 1307-1308
- Carotid pulse, in acute aortic regurgitation 868
- Carotid sinus hypersensitivity, syncope with 178
- Carotid sinus massage
- in paroxysmal supraventricular tachycardia 889
- in syncope 178-179
- Carotid sinus syndrome 178, 181
- Carotidynia 1350
- Carpal tunnel syndrome 540-541, 541f
- Carteolol
- in glaucoma 1300t
- in hypertension 843t
- Cartilage
- age-related changes in 470
- calcification of 496-497
- degeneration of, in osteoarthritis 490
- Caruncle, urethral 1200
- Carvallo's sign 876-877
- Carvedilol
- in heart failure 909
- in hypertension 843t
- Case management 53
- Caspofungin 1367t
- Casts, for fractures 218-219, 219t
- Cataracts 1290-1291, 1293-1295
- Catecholamines, age-related changes in 816t, 820-821
- Catheterization
- cardiac
- in cardiovascular disorders 825t, 832
- in stable angina 857
- urethral
- urinary
- condom 976, 978
- in detrusor overactivity 976
- in detrusor underactivity 979, 980
- infection with 985-987
- long-term use guidelines for 987t
- CBC (complete blood count) 1385
- Cecum
- cancer of 1111
- volvulus of 1124-1125
- Cefaclor 1370t
- Cefadroxil 1370t
- in endocarditis prophylaxis 881t
- Cefazolin 1369t
- in endocarditis prophylaxis 881t
- in infective endocarditis 883t
- Cefepime 1369t
- Cefixime 1370t
- Cefmenoxime 1369t
- Cefmetazole 1369t
- Cefoperazone 1369t
- Cefotaxime 1369t
- in infective endocarditis 884t
- Cefotetan 1369t
- Cefoxitin 1369t
- Cefpirome 1369t
- Cefpodoxime 1370t
- Cefprozil 1370t
- Ceftazidime 1369t
- in infective endocarditis 884t
- Ceftibuten 1370t
- Ceftizoxime 1369t
- Ceftriaxone 1369t
- in infective endocarditis 883t, 884t
- Cefuroxime 1369t, 1370t
- Celecoxib 386t, 390 (see also COX-2 inhibitors)
- in osteoarthritis 492t
- Celestin's tube, in esophageal tumor 1136
- Celiac axis, obstruction of 1119
- Celiac disease 1090, 1099t
- Cell death 6, 6
- Cellulitis, venous ulcers and 1253
- Centigrade scale 1387
- Central nervous system
- age-related changes in 380-383, 381t, 382t
- examination of 36-38
- Central sleep apnea 461-462
- Central venous pressure, estimation of 824
- Cephalexin 1370t
- in endocarditis prophylaxis 881t
- Cephalosporins 1366, 1369t-1370t
- in cellulitis 1253
- Cephalothin 1369t
- Cephamycin 1369t
- Cephapirin 1369t
- Cephradine 1369t, 1370t
- Cerebellar tremor 432
- Cerebellopontine angle, tumor of 1330t
- Cerebellum
- hemorrhage in 420t
- ischemia of 405-406
- Cerebral arteries
- atherosclerosis of 404f-405f, 407-408
- Cerebral blood flow
- age-related changes in 381, 845
- in dizziness 191t
- Cerebral edema, with hypernatremia treatment 568
- Cerebrospinal fluid, in subarachnoid hemorrhage 417-418
- Cerebrovascular disease 397-423 (see also Stroke)
- mortality rates for 12, 13t
- Cerebrovascular insufficiency, syncope with 175
- Cerivastatin 617, 618t, 621
- Cerulein test 1103
- Cerumen 1334
- tinnitus and 1330t, 1334
- Cervical hypertrophic osteoarthropathy 1037
- dysphagia in 1032, 1033
- Cervical spine
- arthritis-related pain in 1350
- spondylosis of 487
- dizziness with 185t
- traction for 277
- Cervix
- biopsy of 1206
- cancer of 1205-1206
- Pap test for 718t
- screening for 48t
- hyperplasia of 1206
- Cevimeline
- in xerostomia 1029
- Chalazia 1311
- Chaplain, hospital 148
- Charles Bonnet syndrome 348
- Cheilitis 1019
- Chemical peel 1238
- Chemotherapy, cancer 717-719, 720t-721t
- in acute leukemia 726-727
- acute leukemia after 725
- in bladder cancer 993, 994
- in breast cancer 1224-1225, 1226t-1227t, 1227-1228
- in chronic leukemia 732
- in colorectal cancer 1144
- diarrhea with 1066-1068
- in endometrial cancer 1204
- in gastric cancer 1138
- in Hodgkin's disease 746, 746t, 747t
- in lung cancer 805
- in multiple myeloma 735-736
- in myelodysplastic syndromes 742
- myelodysplastic syndromes after 739
- in non-Hodgkin's lymphoma 750-752, 752t
- in pancreatic cancer 1148
- in Waldenström's macroglobulinemia 739
- in Zollinger-Ellison syndrome 1049
- Cherry angioma 1242t
- Chest
- pain in, of angina pectoris 855
- in physical examination 28t, 34
- surgery on 264
- Chest x-ray (see Radiography)
- Chloral hydrate 457
- Chlorambucil
- in chronic leukemia 732
- sexual function and 1164t
- Chloramphenicol 1373t
- Chlordiazepoxide
- adverse effects of 64t-65t
- aging effect on 62
- sexual function and 1164t
- Chloride, in metabolic alkalosis 586
- Chlormadinone, sexual function and 1164t
- Chloroquine, tinnitus with 1330t
- Chlorothiazide
- in hypertension 839t
- Chlorpheniramine, adverse effects of 63t
- Chlorpromazine
- sexual function and 1163t, 1164t
- Chlorpropamide
- adverse effects of 64t
- contraindication to 73
- in diabetes mellitus 632t
- Chlortetracycline 1373t
- sexual function and 1164t
- Chlorthalidone
- in hypertension 839t
- in hypocalcemia 575
- Chlorzoxazone 395t
- adverse effects of 64t
- Cholangiocarcinoma 1149
- Cholangiopancreatography, endoscopic 1011-1013
- Cholangitis 1126-1127
- Cholecystectomy, in gallstones 1125-1126
- Cholecystitis
- acalculous 1127
- gallstones and 1125, 1126
- Cholecystokinin 1006
- Cholecystokinin test 1103
- in fatty diarrhea 1090-1091
- Cholelithiasis 1005-1006, 1125-1126
- estrogen replacement therapy and 1215
- impacted 1116
- intestinal migration of 1127-1128
- pancreatitis with 1127
- Cholestasis, malabsorption with 1098t
- Cholesteatoma 1338-1339
- tinnitus and 1330t
- Cholesterol (see also Lipoproteins, disorders of)
- blood
- age-related changes in 607, 1384t
- atherosclerosis and 850
- coronary artery disease and 606, 850, 853
- elevated levels of 606, 608t (see also Hypercholesterolemia)
- screening for 47t
- in malnutrition 600, 600t
- measurement of 611, 612t
- postmenopausal 1210
- progestin effects on 1216
- stroke and 606
- dietary 614t
- renal embolization with 959
- Cholestyramine
- in antibiotic-associated diarrhea 1068
- in diarrhea 1091t
- digoxin interaction with 68t
- in lipoprotein disorders 616-617, 618t
- Choline acetyltransferase 381, 382t
- Cholinergic crisis, with myasthenia gravis treatment 522
- Cholinesterase inhibitors 364,
366t
- in Alzheimer's disease 365
- Chondrocalcinosis 470, 496-497
- Chondrocytes 470
- Chondrodermatitis nodularis chronica helicis 1342
- Chondroitin sulfate 493
- Chorea 430t
- Chromium 594
- Chronic disease
- prevalence of 15t
- preventive managed care for 163-164
- quality of life and 113
- Chronic obstructive pulmonary disease (COPD) 779-787, 783t
- acute exacerbations of 786
- adverse drug interactions with 67t
- anesthesia effects of 261t
- cigarette smoking and 779
- end-stage 786-787, 787
- mortality rates for 13t, 14f
- occupational therapy for 290
- patient education in 809
- prevention of 49t, 51
- rehabilitation therapy for 786, 806-809
- ventilatory failure and 786, 787-788
- Chvostek's sign 574
- Cidofovir 1367t
- Cigarette smoking 341
- atherosclerosis and 850, 851, 915
- cessation of,
- in disease prevention 51t
- COPD and 779, 786
- lung cancer and 800
- in patient assessment 47t
- theophylline interaction with 68t
- Cilostazol 918
- Cimetidine
- alcohol interaction with 335
- drug interactions with 68t
- in peptic ulcer disease 1046
- sexual function and 1163t, 1164t
- Cinoxacin 1372t
- Ciprofloxacin 1366, 1372t
- in Crohn's disease 1064t, 1065
- in diarrhea 1091t
- drug interactions with 68t
- Circadian rhythm disturbance 457-458
- Cirrhosis
- biliary 1072
- hepatocellular carcinoma and 1149
- Cisapride
- in bezoar therapy 1051
- in gastroesophageal reflux disease 1040
- Citalopram 72
- in obsessive-compulsive disorder 326
- Cladribine 720t
- Clarithromycin 1371t
- in endocarditis prophylaxis 881t
- in Helicobacter pylori infection 1047
- Claudication 915-916, 918-919
- of jaw 508
- in spinal stenosis 488
- Claustrophobia 327
- Clavulanate 1368t
- Claw toe 36
- Clidinium, adverse effects of 64t-65t
- Climacteric (see Menopause)
- Clindamycin 1374t
- in endocarditis prophylaxis 881t
- Cloacogenic carcinoma 1144
- Clobetasol propionate
- in lichen sclerosus 1201
- in xerosis 1247t
- Clofibrate, sexual function and 1164t
- Clonazepam
- in pain management 394t
- Clonidine
- for hot flashes 1211
- in hypertension 843t
- in hypotension 848
- sexual function and 1163t, 1164t
- Clopidogrel 702
- in ischemic stroke 411
- Clostridium difficile infection
- in antibiotic-associated diarrhea 1066, 1067, 1369t- 1374t
- postoperative 254
- treatment of 1371t-1375t
- Clotrimazole
- in oral candidiasis 1018
- Cloxacillin 1367t-1368t
- Clozapine 333
- in parkinsonism 440
- Clumsy hand syndrome 412t
- CNS (see Central nervous system)
- Coagulation factors
- age-related changes in 1384t
- in hypercoagulable states 688-689
- Cocaine, sexual function and 1164t
- Cochlear implant 1326
- Cockcroft-Gault formula 59, 1385
- Codeine 387t
- in diarrhea 1091t
- Cognition
- aging and 308, 656t
- in comprehensive geriatric assessment 43
- impairment of (see also Delirium; Dementia)
- anxiety and 326
- decision making and 128, 130, 1228
- dental care and 1014
- driving and 234
- at emergency department admission 94-95
- in parkinsonism 435
- postoperative 251
- quality of life and 114
- screening for47t
- in mental status examination 348-349
- perimenopausal changes in 1209
- Cognitive-behavioral therapy
- in osteoarthritis 491
- in panic disorder 327
- Cognitive therapy, in depression 319-320
- Cohen-Mansfield Agitation Inventory 372
- Colchicine
- in gout 496
- sexual function and 1164t
- Cold agglutinin disease 679, 681-682
- Cold therapy (cryotherapy) 276
- Colectomy
- in Crohn's disease 1065
- in ulcerative colitis 1062
- Colestipol
- in antibiotic-associated diarrhea 1068
- digoxin interaction with 68t
- in lipoprotein disorders 616-617, 618t
- Colic, biliary 1125
- Colistin 1371t
- Colitis
- antibiotic-associated 1066-1068
- collagenous 1087
- ischemic 1003, 1117-1118
- lymphocytic 1087
- microscopic 1087, 1092
- pseudomembranous 1067
- antibiotic use and 254
- ulcerative 1059-1062, 1061t
- Collagen injection
- for bladder outlet incompetence 978
- in photoaging 1238
- Colles' fractures 220-221
- Colon (see also Bowel)
- age-related changes in 1002-1003
- angiodysplasia of 1057-1058
- bleeding in 1111
- bleeding from 1111
- cancer of 1140-1141
- detection of 1009, 1010
- screening for 48t, 718t
- ulcerative colitis and 1059-1060
- Crohn's disease of 1062-1066, 1064t
- diverticular disease of 1053-1057, 1055t
- bleeding in 1111
- endoscopy of 1010-1011
- ischemia of 1003, 1117-1118
- obstruction of 1113-1117
- peptic ulcer penetration of 1044
- polyps of 1140-1141
- detection of 1009
- pseudo-obstruction of 1116
- radiation injury to 1122
- sigmoidoscopy of 1009-1010
- spastic 1068-1070
- ulcerative inflammation of 1059-1062, 1061t
- volvulus of 1124-1125
- Colonoscopy 1010-1011
- in angiodysplasia 1057-1058
- in antibiotic-associated diarrhea 1067
- for cancer screening 48t, 718t
- in constipation 1083
- in Crohn's disease 1063
- in diarrhea 1090
- in diverticulitis 1056
- in gastrointestinal tract bleeding 1107
- in intestinal tract obstruction 1115
- in ischemic colitis 1118
- in polyps 1141
- in ulcerative colitis 1059-1060
- Colorectal disorders (see Colon; Rectum)
- Color vision 1291-1292
- Colostomy, sexual activity after 1162-1163
- Colovesical fistula 1202
- Colporrhaphy 978
- Coma
- systemic hypoperfusion and 415
- Communicating artery 404f-405f
- Communication
- among physicians 53, 95
- therapeutic privilege and 133
- physician-surrogate 137
- Compartment syndrome 214
- Competence 130-131, 350
- Complement
- age-related changes in 1353
- in Alzheimer's disease 1359
- Complete blood count (CBC) 1385
- Compliance, with drug therapy 69-70
- Comprehensive geriatric assessment 40-46, 41t, 43t, 44t, 45t (see also Patient history; Physical examination)
- cognition in 43
- functional ability in 42-43, 44t, 45t
- physical health in 43
- socioenvironmental situation in 46
- Compression therapy
- in stasis dermatitis 1252
- in venous ulcers 1253
- Compulsions 347
- Computed tomography
- in aortic dissection 940
- in cardiovascular disorders 825t, 831
- in colorectal cancer 1143
- in coronary artery disease 825t, 831
- in Crohn's disease 1063-1064
- in dementia 363
- in diverticulitis 1056
- of fractures 216
- in hemorrhagic stroke 417, 418, 420
- in ischemic stroke 408, 414
- in muscular disorders 515
- in pulmonary embolism 775
- in pulmonary interstitial disease 797
- in subdural hematoma 423
- Conditioning exercises 273
- Condom catheter 976, 978
- Conduction disturbances 895-900, 895t (see also Arrhythmias)
- Condylomata acuminata 1190
- Confidentiality 133
- Confusion (see also Delirium)
- in dying patient 120
- during hospitalization 100
- opioid-induced 391
- Confusion Assessment Method 345t, 353, 355t
- Congestive heart failure (see Heart failure)
- Congregate care (see Assisted-living facilities)
- Conjunctiva
- age-related changes in 1285-1286
- Conjunctivitis, seborrheic 1250, 1251
- Connective tissue 470-471
- age-related changes in 467
- Constipation 1080-1085, 1081t, 1084t
- drug-related 1081t, 1085
- in dying patient 119
- opioid-induced 392
- in parkinsonism 437, 438
- Constriction rings, in erectile dysfunction 1170
- Contact dermatitis 1249-1250
- venous ulcers and 1253-1254
- Continuing care retirement communities 171 (see also Life-care communities)
- Continuity of care 87-112 (see also specific care delivery sites)
- Continuous positive airway pressure (CPAP)
- in obstructive sleep apnea 461
- in respiratory failure 789, 793
- Contrast sensitivity 1290
- Coombs' test
- in chronic leukemia 730
- in drug-induced hemolytic anemia 680
- Coordination exercises 272
- COPD (see Chronic obstructive pulmonary disease)
- Copper 1384t
- Cor pulmonale 787
- Cordotomy 396
- Cornea
- age-related changes in 1287
- Fuchs' endothelial dystrophy of 1314
- Cornell Scale for Depression in Dementia 345t
- Coronary arteries
- angiography of 832, 832t
- calcification of 829
- disease of 853-863
- abdominal aneurysm and 937
- anemia in 674-675
- anesthesia effects of 260t
- angina pectoris in 855-858
- blood cholesterol and 606, 612-624, 614t, 616t, 618t-620t, 850, 853
- cardiac catheterization in 825t, 832
- chemoprevention of 49t
- coronary angiography in 832, 832t
- coronary artery bypass surgery for 942-944, 945t
- electron-beam computed tomography in 825t, 831
- estrogen and 655
- heart failure in 900
- hyperhomocysteinemia in 852
- mortality rate for 853
- myocardial infarction in 858-863, 862t-863t
- percutaneous coronary interventions for 944-947, 945t
- prevention of 51t
- radionuclide ventriculography in 825t, 831
- stress testing in 825t, 827-828, 827t
- thallium-201 perfusion scintigraphy in 825t, 827t, 828-829
- Coronary artery bypass surgery 942-944, 945t
- sexual activity and 1161-1162
- valve replacement and 949
- Corticosteroids (see also specific drugs)
- in bullous pemphigoid 1256-1257
- in chronic leukemia 732
- in COPD 784, 787
- in dermatitis 1250
- in giant cell arteritis 509
- in gout 496
- in herpes zoster infection 1260
- in idiopathic autoimmune hemolysis 681
- in lichen sclerosus 1201
- in lichen simplex chronicus 1251
- in multiple myeloma--related hypercalcemia 736-737
- in myasthenia gravis 522
- in myelofibrosis 713
- myopathy with 527-528
- in oral ulcers 1019
- in osteoarthritis 493
- in pemphigus vulgaris 1258
- in polymyalgia rheumatica 509
- in psoriasis 1254-1255
- in pulmonary interstitial disease 799
- in rheumatoid arthritis 502
- sexual function and 1164t
- in skin disorders 1243
- in stasis dermatitis 1252
- in subarachnoid hemorrhage 418
- in systemic lupus erythematosus 505
- topical 1247t
- in ulcerative colitis 1060-1061, 1062
- in vulvar squamous hyperplasia 1201
- in xerosis 1248
- Corticotropin
- sexual function and 1164t
- in ulcerative colitis 1060, 1061t
- Cosmetic surgery 240-241, 1238
- Co-trimoxazole (see Trimethoprim-sulfamethoxazole)
- Cotton-wool spots 1302
- Coughing
- in COPD 782
- syncope with 175
- Coumarin (see Warfarin)
- Counseling
- in alcoholism 337-338, 339
- from clergy 148
- Courvoisier's sign 1147
- COX-2 inhibitors 74, 390, 386t
- adverse effects of 492
- in osteoarthritis 491, 492t
- in rheumatoid arthritis 501-502
- in systemic lupus erythematosus 504
- Cramps
- in intestinal tract obstruction 1114
- muscle 512, 513
- in leg 533-535, 534f
- Cranial nerves
- evaluation of 36-37
- palsy of 1311-1312
- C-reactive protein, in giant cell arteritis 508
- Creams 1244t
- Creatine kinase
- age-related change in 1384t
- in inclusion body myositis 524
- isoforms of 513
- in muscular disorders 513
- in myocardial infarction 858-859
- Creatinine
- blood
- in dehydration 562
- in hyponatremia 565t
- urinary, for muscle mass measurement 520
- Creatinine clearance 1385
- age-related changes in 952, 1384t
- Cockcroft-Gault formula for 59, 1385
- Credé's maneuver 979
- Crescendo angina 855
- CREST syndrome 922
- Creutzfeldt-Jakob disease 370, 448-449
- Cricoarytenoiditis 1349
- Critical care quadriparesis 527
- Crohn's disease 1062-1066, 1064t, 1099t
- Cronkhite-Canada syndrome 1136
- Cryoprecipitate 701
- Cryotherapy
- in actinic keratoses 1277
- in pain management 396
- in squamous cell carcinoma 1281
- Crystal deposition disease 496-497
- CT (see Computed tomography)
- Cuff weight exercise 304
- Cushing's disease (syndrome)
- hypertension with 837
- muscle weakness in 527-528
- Custodial care 166
- Cyanosis 922
- Cyclandelate, adverse effects of 65t
- Cyclobenzaprine
- adverse effects of 64t
- in pain management 395t
- Cyclooxygenase
- isoforms of 491
- Cyclophosphamide
- in breast cancer 1226t
- in bullous pemphigoid 1257
- in idiopathic autoimmune hemolysis 681
- in non-Hodgkin's lymphoma 752t
- in pulmonary interstitial disease 799
- sexual function and 1164t
- Cyclosporine
- in psoriasis 1255
- statin interaction with 621
- in ulcerative colitis 1060
- Cyproheptadine, adverse effects of 64t
- Cyst
- hepatic 1129
- hydatid 1129
- pancreatic 1132-1133
- popliteal, in deep vein thrombosis 926
- renal 989
- Cystadenocarcinoma, pancreatic 1145
- Cystectomy 992
- Cystitis 984-985
- interstitial, in prostatitis 1188, 1189
- nitrofurantoin for 1374t
- sexual activity and 1161
- Cystocele 974, 1195, 1196f, 1200
- Cystoplasty 976
- Cystoscopy 992
- Cytarabine 726
- Cytochrome P-450 enzyme system
- in drug metabolism 57, 58t
- H2 blocker interaction with 1046
- Cytokines, in malnutrition 596
- Cytomegalovirus infection 1377t
|
 |
|
|
|
